Nurse Practitioner, Psychiatric/Mental Health · Crete, IL
NPI
1346770914
Since 2017
Specialty
Nurse Practitioner, Psychiatric/Mental Health
Code 363LP0808X
Group practices
4
Medicare group memberships
Hospitals
0
Hospital affiliations
1328 Main St Unit B
Crete, IL, 60417
Phone (708) 277-6924
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.8M
8,190 services
Medicare patients, 2024
753
Average age 71
Drug cost, 2024
$690K
8,373 prescriptions
Company payments, 2025
$19K
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark Norbert P Guiab was code 99309 (snf e&m), 1,505 times for 305 patients. In total Mark Norbert P Guiab billed 8,190 services in 34 codes, and Medicare paid $4.8M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-02-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99309 SNF E&M | Office | 1,505 | 305 | $70.98 | $107K |
| Q4191 Restorigin, per square centimeter | Office | 1,030 | 19 | $1,131.28 | $1.2M |
| 99308 SNF E&M | Office | 909 | 178 | $45.51 | $41K |
| Q4221 Amniowrap2, per square centimeter | Office | 809 | 17 | $1,449.16 | $1.2M |
| 99213 Office E&M - Established | Office | 561 | 78 | $50.15 | $28K |
| 99214 Office E&M - Established | Office | 387 | 96 | $78.50 | $30K |
| 99348 Home E&M - New and Established | Office | 305 | 88 | $45.93 | $14K |
| 99309 SNF E&M | Facility | 258 | 84 | $73.48 | $19K |
| 15271 Skin and Soft Tissue Substitutes | Office | 234 | 40 | $105.77 | $25K |
| 99310 SNF E&M | Facility | 84 | 77 | $105.17 | $8,834 |
| 15275 Skin and Soft Tissue Substitutes | Office | 76 | 14 | $111.43 | $8,469 |
| 99306 SNF E&M | Office | 43 | 43 | $123.72 | $5,320 |
| 99349 Home E&M - New and Established | Office | 31 | 11 | $82.07 | $2,544 |
| 99310 SNF E&M | Office | 28 | 22 | $103.00 | $2,884 |
| 99308 SNF E&M | Facility | 25 | 22 | $48.49 | $1,212 |
By year: 2022 $253K for 4,145 services; 2023 $999K for 4,785 services; 2024 $4.8M for 8,190 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mark Norbert P Guiab prescribed most often to Medicare patients was Quetiapine Fumarate, with 647 prescriptions and refills. In total Mark Norbert P Guiab wrote 8,373 Medicare prescriptions that cost $690K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Quetiapine Fumarate Generic | 647 | 654 | 54 | $16K |
| Clonazepam Generic | 527 | 531 | 42 | $5,020 |
| Divalproex Sodium Generic | 525 | 528 | 51 | $21K |
| Duloxetine Hcl Generic | 415 | 416 | 34 | $7,122 |
| Trazodone Hcl Generic | 395 | 398 | 51 | $4,847 |
| Risperidone Generic | 388 | 393 | 29 | $4,433 |
| Sertraline Hcl Generic | 363 | 367 | 39 | $3,608 |
| Mirtazapine Generic | 314 | 316 | 42 | $6,525 |
| Lorazepam Generic | 303 | 304 | 46 | $4,219 |
| Olanzapine Generic | 262 | 265 | 27 | $5,532 |
| Alprazolam Generic | 211 | 211 | 26 | $1,792 |
| Topiramate Generic | 201 | 204 | 13 | $3,052 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 198 | 199 | 13 | $4,762 |
| Escitalopram Oxalate Generic | 188 | 190 | 20 | $2,326 |
| Clozapine Generic | 188 | 191 | 11 | $21K |
Brand drugs: 568 claims; generic drugs: 7,805 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark Norbert P Guiab $19K ($19K in general payments such as food, travel and fees) from 8 companies. The largest payer was Otsuka America Pharmaceutical, Inc. with $18K.
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. 4578.T | 52 | $18K |
| Alpha Cognition USA, Inc. ACOG | 8 | $343 |
| Teva Pharmaceuticals USA, Inc. TEVA | 2 | $249 |
| ACADIA Pharmaceuticals Inc ACAD | 3 | $137 |
| Neurocrine BioSciences, Inc. NBIX | 1 | $109 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $29.61 |
| Lundbeck LLC | 1 | $18.76 |
| SK Life Science, Inc. | 1 | $16.87 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.